ALS Association Association Urges FDA to Approve New ALS Treatment Just Approved in Canada
June 14, 2022
June 14, 2022
WASHINGTON, June 14 (TNSjou) -- The Amyotrophic Lateral Sclerosis Association issued the following news release:
Amylyx Pharmaceuticals, Inc. announced that Health Products and Food Branch (HPFB) of Health Canada officially approved ALBRIOZA, known as AMX0035 in the United States, a new treatment for amyotrophic lateral sclerosis (ALS). Clinical trials showed the drug to be safe and effective for people living with ALS, a fatal neurodegenerative disease. The Food and Drug Administra . . .
Amylyx Pharmaceuticals, Inc. announced that Health Products and Food Branch (HPFB) of Health Canada officially approved ALBRIOZA, known as AMX0035 in the United States, a new treatment for amyotrophic lateral sclerosis (ALS). Clinical trials showed the drug to be safe and effective for people living with ALS, a fatal neurodegenerative disease. The Food and Drug Administra . . .